Literature DB >> 17951068

The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction.

Pauline Lafenêtre1, Francis Chaouloff, Giovanni Marsicano.   

Abstract

The endocannabinoid system recently emerged as an important modulator of many neuronal functions. Among them, the control of anxiety and acquired fear represents nowadays one of the most interesting fields of research. Despite contrasting results obtained by the use of cannabinoid receptor agonists in experimental animals, there is growing evidence that the physiological activation of the endocannabinoid system plays a central role in the control of basal anxiety levels and in the modulation of fear responses. This review will summarise recent data on the role of the endocannabinoid system in most commonly used tests of anxiety and in the processing of acquired fear, with particular attention to its involvement in fear extinction. Finally, a neurobiological model possibly able to implement the role of the endocannabinoid system in these processes will be proposed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951068     DOI: 10.1016/j.phrs.2007.09.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  38 in total

Review 1.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

2.  Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety.

Authors:  Lauren C Harte-Hargrove; Diana L Dow-Edwards
Journal:  Behav Brain Res       Date:  2012-03-05       Impact factor: 3.332

3.  Cannabinoid CB₂ receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.

Authors:  W M Olango; M Roche; G K Ford; B Harhen; D P Finn
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.

Authors:  Thibaut R Pardo-García; Nadira Yusif-Rodriguez; Guillermo Yudowski; Carmen S Maldonado-Vlaar
Journal:  Neurosci Lett       Date:  2020-05-16       Impact factor: 3.046

6.  Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.

Authors:  Christine A Rabinak; Mike Angstadt; Maryssa Lyons; Shoko Mori; Mohammed R Milad; Israel Liberzon; K Luan Phan
Journal:  Neurobiol Learn Mem       Date:  2013-09-19       Impact factor: 2.877

Review 7.  Fear extinction as a model for translational neuroscience: ten years of progress.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Annu Rev Psychol       Date:  2012       Impact factor: 24.137

8.  Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.

Authors:  Deanna L Kelly; David A Gorelick; Robert R Conley; Douglas L Boggs; Jared Linthicum; Fang Liu; Stephanie Feldman; M Patricia Ball; Heidi J Wehring; Robert P McMahon; Marilyn A Huestis; Stephen J Heishman; Kimberly R Warren; Robert W Buchanan
Journal:  J Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.153

9.  Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.

Authors:  Matthew S Powers; Gustavo D Barrenha; Nate S Mlinac; Eric L Barker; Julia A Chester
Journal:  Psychopharmacology (Berl)       Date:  2010-09-14       Impact factor: 4.530

10.  Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Authors:  Maria Sabrina Spano; Liana Fattore; Francesca Cadeddu; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.